← FDA DRUG APPROVALS

FDA ANDA · ANDA089488

DIPHENHYDRAMINE HYDROCHLORIDE

Sponsor: SUN PHARM INDUSTRIES

APPLICATION
ANDA089488
TYPE
ANDA
ORIGINAL APPROVAL
1987-01-02
LATEST ACTION
2000-05-16
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

DIPHENHYDRAMINE HYDROCHLORIDEDiscontinued
DIPHENHYDRAMINE HYDROCHLORIDE 25MG · CAPSULE · ORAL

Approval history

2000-05-16Manufacturing (CMC) · Supplement 8AP
2000-05-16Manufacturing (CMC) · Supplement 7AP
1998-11-05Manufacturing (CMC) · Supplement 6AP
1998-04-02Manufacturing (CMC) · Supplement 5AP
1997-12-05Manufacturing (CMC) · Supplement 4AP
1997-02-24Manufacturing (CMC) · Supplement 3AP
1994-01-12Manufacturing (CMC) · Supplement 2AP
1991-11-08Manufacturing (CMC) · Supplement 1AP
1987-01-02OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →